Advertisement
Home »

CAM Use in More Than One-Third of Patients With CKD

Oct 02, 2023

REFERENCES & ADDITIONAL READING

Ben Salah G, Farooqui M, Salem Alshammari M, et al. Prevalence, types and disclosure of complementary and alternative medicine (CAM) use among chronic kidney disease (CKD) patients in Saudi Arabia. J Pharm Policy Pract. 2023;16(1):89. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347759/.

Assiry A, Alshahrani S, Banji D, Banji OJ, Syed NK, Alqahtani SS. Public awareness of chronic kidney disease in Jazan Province, Saudi Arabia—a cross-sectional survey. Healthcare. 2022;10(8):1377-2022.

Alrowais NA, Alyousefi NA. The prevalence extent of complementary and alternative medicine (CAM) use among Saudis. Saudi Pharm J. 2017;25(3):306-318.

Hassanien AA, Al-Shaikh F, Vamos EP, Yadegarfar G, Majeed A. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. JRSM Short Rep. 2012;3(6):1-21.

Al-Rubeaan K. The impact of diabetes mellitus on health and economy of Gulf Cooperation Council countries. Diabetes Manag. 2014;4:381-390.

ABOUT THE EXPERTS

  • Maryam Farooqui, PhD, BPharm, MPharm
    Associate Professor
    Department of Pharmacy Practice
    Unaizah College of Pharmacy
    Qassim University
    Saudi Arabia

    Maryam Farooqui, PhD, BPharm, MPharm, has no financial disclosures to report that are relevant to this article.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement